ESTRATAB Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Estratab, and when can generic versions of Estratab launch?
Estratab is a drug marketed by Solvay and is included in four NDAs.
The generic ingredient in ESTRATAB is estrogens, esterified. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estrogens, esterified profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ESTRATAB?
- What are the global sales for ESTRATAB?
- What is Average Wholesale Price for ESTRATAB?
Summary for ESTRATAB
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 26 |
| Patent Applications: | 1,042 |
| DailyMed Link: | ESTRATAB at DailyMed |
US Patents and Regulatory Information for ESTRATAB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solvay | ESTRATAB | estrogens, esterified | TABLET;ORAL | 086715-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Solvay | ESTRATAB | estrogens, esterified | TABLET;ORAL | 083857-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Solvay | ESTRATAB | estrogens, esterified | TABLET;ORAL | 083209-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Solvay | ESTRATAB | estrogens, esterified | TABLET;ORAL | 083856-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
